• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery.

作者信息

Osataphan Soravis, Patell Rushad, Babuta Mrigya, Rosovsky Rachel P, Hisada Yohei, Edmiston Charly, Elavalakanar Pavania, Pfeffer Michael A, Bregar Amy, Ramos Amanda, Garrett Leslie, Ren Siyang, Neuberg Donna, Szabo Gyongyi, Flaumenhaft Robert, Mackman Nigel, Shea Meghan, Zwicker Jeffrey I

机构信息

Division of Hematology and Hematologic Malignancies, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

出版信息

Blood Adv. 2025 Sep 9;9(17):4472-4476. doi: 10.1182/bloodadvances.2025016107.

DOI:10.1182/bloodadvances.2025016107
PMID:40472284
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC12410534/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873a/12410534/86a62db74bb4/BLOODA_ADV-2025-016107-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873a/12410534/86a62db74bb4/BLOODA_ADV-2025-016107-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873a/12410534/86a62db74bb4/BLOODA_ADV-2025-016107-gr1.jpg

相似文献

1
The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery.卵巢癌手术后瑞舒伐他汀降低循环组织因子细胞外囊泡的疗效。
Blood Adv. 2025 Sep 9;9(17):4472-4476. doi: 10.1182/bloodadvances.2025016107.
2
The Administration of Circulating Extracellular Vesicles Modified by Anesthesia and Surgery Induces Delirium-Like Behaviors in Aged Mice.麻醉和手术修饰的循环细胞外囊泡给药诱导老年小鼠出现谵妄样行为。
CNS Neurosci Ther. 2025 Jun;31(6):e70483. doi: 10.1111/cns.70483.
3
Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles.通过模拟细胞外囊泡驱动的输卵管上皮重编程来定义卵巢癌癌前状态
Cancer Res Commun. 2025 Aug 1;5(8):1266-1281. doi: 10.1158/2767-9764.CRC-25-0064.
4
Early assessment of circulating exosomal lncRNA-GC1 for monitoring neoadjuvant chemotherapy response in gastric cancer.早期评估循环外泌体 lncRNA-GC1 用于监测胃癌新辅助化疗反应。
Int J Surg. 2023 May 1;109(5):1094-1104. doi: 10.1097/JS9.0000000000000249.
5
Engineering modification of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorates polycystic ovary syndrome by enhancing the ovarian environment and regulating follicular development.人脐带间充质干细胞来源的小细胞外囊泡的工程化修饰通过改善卵巢环境和调节卵泡发育来改善多囊卵巢综合征。
Stem Cell Res Ther. 2025 Sep 1;16(1):481. doi: 10.1186/s13287-025-04610-0.
6
The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review.瑞舒伐他汀的药物遗传学及其治疗意义：一项系统评价。
Pharmacogenomics. 2025 May-Jun;26(7-9):311-329. doi: 10.1080/14622416.2025.2547565. Epub 2025 Aug 21.
7
Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure.替皮法尼布减少细胞外囊泡并预防心力衰竭。
Circ Res. 2024 Jul 5;135(2):280-297. doi: 10.1161/CIRCRESAHA.123.324110. Epub 2024 Jun 7.
8
Lipid-lowering efficacy of rosuvastatin.瑞舒伐他汀的降脂疗效。
Cochrane Database Syst Rev. 2014 Nov 21;2014(11):CD010254. doi: 10.1002/14651858.CD010254.pub2.
9
Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.大剂量瑞舒伐他汀负荷量在接受经皮冠状动脉介入治疗的中国急性冠脉综合征患者中的作用：一项系统评价和荟萃分析。
PLoS One. 2017 Feb 23;12(2):e0171682. doi: 10.1371/journal.pone.0171682. eCollection 2017.
10
Comparative Efficacy and Safety of Daily Versus Alternate-Day Dosing of Rosuvastatin in Diabetic Dyslipidemia: An Open-Label Clinical Trial.瑞舒伐他汀每日给药与隔日给药治疗糖尿病血脂异常的疗效和安全性比较：一项开放标签临床试验
Cureus. 2025 Jun 6;17(6):e85457. doi: 10.7759/cureus.85457. eCollection 2025 Jun.

本文引用的文献

1
Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology.比较测量血浆样本中外泌体组织因子的检测方法：ISTH SSC 血管生物学小组委员会的交流。
J Thromb Haemost. 2024 Oct;22(10):2910-2921. doi: 10.1016/j.jtha.2024.05.037. Epub 2024 Jun 25.
2
Updates in the Incidence, Pathogenesis, and Management of Cancer and Venous Thromboembolism.癌症和静脉血栓栓塞症的发病率、发病机制和治疗的最新进展。
Arterioscler Thromb Vasc Biol. 2023 Jun;43(6):824-831. doi: 10.1161/ATVBAHA.123.318779. Epub 2023 May 4.
3
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update.
静脉血栓栓塞症预防和治疗癌症患者：ASCO 指南更新。
J Clin Oncol. 2023 Jun 1;41(16):3063-3071. doi: 10.1200/JCO.23.00294. Epub 2023 Apr 19.
4
Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.卵巢癌大型手术后静脉血栓栓塞和出血的风险：标准住院期与延长的血栓预防时长。
J Thromb Haemost. 2023 Feb;21(2):294-302. doi: 10.1016/j.jtha.2022.11.017. Epub 2022 Dec 22.
5
How statin drugs affect exosomes?他汀类药物如何影响外泌体？
J Cell Biochem. 2023 Feb;124(2):171-180. doi: 10.1002/jcb.30363. Epub 2022 Dec 24.
6
Annexin V and tissue factor microparticles as biomarkers for predicting deep vein thrombosis in patients after joint arthroplasty.膜联蛋白V和组织因子微粒作为关节置换术后患者深静脉血栓形成的预测生物标志物。
Clin Chim Acta. 2022 Nov 1;536:169-179. doi: 10.1016/j.cca.2022.09.011. Epub 2022 Oct 1.
7
Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications.癌症相关血栓栓塞中的组织因子：可能的机制和临床应用。
Br J Cancer. 2022 Dec;127(12):2099-2107. doi: 10.1038/s41416-022-01968-3. Epub 2022 Sep 12.
8
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods.血浆组织因子阳性细胞外囊泡的测量：当前方法的优缺点。
Curr Opin Hematol. 2022 Sep 1;29(5):266-274. doi: 10.1097/MOH.0000000000000730. Epub 2022 Jul 11.
9
Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial.瑞舒伐他汀治疗可降低静脉血栓栓塞（VTE）后血浆促凝磷脂活性：一项随机对照试验。
J Thromb Haemost. 2022 Apr;20(4):877-887. doi: 10.1111/jth.15626. Epub 2022 Jan 8.
10
Comparative Analysis of Platelet-Derived Extracellular Vesicles Using Flow Cytometry and Nanoparticle Tracking Analysis.使用流式细胞术和纳米颗粒跟踪分析对血小板衍生细胞外囊泡进行比较分析
Int J Mol Sci. 2021 Apr 7;22(8):3839. doi: 10.3390/ijms22083839.